Ticker Details
Allogene Therapeutics, Inc.
IPO Date:	October 8, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$690.31M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.42 | 3.24%
Avg Daily Range (30 D):	$0.13 | 4.67%
Avg Daily Range (90 D):	$0.11 | 4.97%

Institutional Daily Volume
Avg Daily Volume:	1.9M
Avg Daily Volume (30 D):	12.67M
Avg Daily Volume (90 D):	7.79M

Trade Size
Avg Trade Size (Sh.):	166
Avg Trade Size (Sh.) (30 D):	310
Avg Trade Size (Sh.) (90 D):	305

Institutional Trades
Total Institutional Trades:	2,998
Avg Institutional Trade:	$1.85M
Avg Institutional Trade (30 D):	$1.65M
Avg Institutional Trade (90 D):	$1.7M
Avg Institutional Trade Volume:	.19M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.41M
Avg Closing Trade (30 D):	$1.82M
Avg Closing Trade (90 D):	$1.79M
Avg Closing Volume:	258.09K

News

Apr 15, 2026 @ 1:50 AM Allogene Therapeutics Announces Pricing of Public ... Source: Na

Dec 16, 2025 @ 6:09 PM Allogene Arbitration Victory Pressures Cellectis S... Source: Vandana Singh

Dec 15, 2025 @ 10:39 PM Allogene Therapeutics Reports Favorable Result for... Source: Allogene Therapeutics

Nov 27, 2025 @ 4:00 PM U.S. CAR T-Cell Therapies Market Grows at 30.4% CA... Source: Towards Healthcare

Jul 23, 2025 @ 1:26 PM High‑Growth Oncology Market Projected For U... Source: Prnewswire

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.77	$-.18	$-.17
Diluted EPS	$-.77	$-.18	$-.17
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-173.76M	$-42.61M	$-38.81M
Operating Income / Loss	$-190.22M	$-46.09M	$-42.4M
Cost of Revenue
Net Cash Flow	$-12.15M	$-21.38M	$13.87M
PE Ratio